TRON scientists publish in Oncoimmunology

Mainz, July 19, 2019 – TRON scientists publish in Oncoimmunology

TRON has published an article on the immunomodulatory effects of the TLR7 agonist SC1 in Oncoimmunology.  Among the exciting results, the authors show that SC1 administration leads to inhibition of tumor growth and prolonged survival, and that this effect is dependent on CD8+ T cells.  Learn more by reading the article.